drugset / Trial / NCT01336387

Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers

NCT01336387 ↗

Phase 1 Terminated 50 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupTriple-blindTreatment

Summary

This randomized phase I trial studies the side effects and the best dose of retinoid 9cUAB30 in healthy volunteers. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of retinoid 9cUAB30 may keep cancer from forming.

Timeline

Start
2011-10
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject UAB30 Other / unclassified — Oral

Indications

No indication recorded.